We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00181688
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : December 5, 2012
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Information provided by (Responsible Party):
Carolyn N. Krasner, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2006
  Study Completion Date : March 2006